材料科学
机制(生物学)
生物物理学
癌症研究
生物医学工程
分子生物学
细胞生物学
纳米技术
医学
生物
物理
量子力学
作者
Jing Liu,Sang Gue Kang,Peng Wang,Yue Wang,Xiaonan Lv,Ying Liu,Fei Wang,Zonglin Gu,Zaixing Yang,Jeffrey K. Weber,Tao Ning,Zhihai Qin,Qing Miao,Chunying Chen,Ruhong Zhou,Yuliang Zhao
出处
期刊:Biomaterials
[Elsevier]
日期:2018-01-01
卷期号:152: 24-36
被引量:26
标识
DOI:10.1016/j.biomaterials.2017.10.027
摘要
Gadolinium-containing fullerenol [email protected]82(OH)22 has demonstrated low-toxicity and highly therapeutic efficacy in inhibiting tumor growth and metastasis through new strategy of encaging cancer, however, little is known about the mechanisms how this nanoparticle regulates fibroblast cells to prison (instead of poison) cancer cells. Here, we report that [email protected]82(OH)22 promote the binding activity of tumor necrosis factor (TNFα) to tumor necrosis factor receptors 2 (TNFR2), activate TNFR2/p38 MAPK signaling pathway to increase cellular collagen expression in fibrosarcoma cells and human primary lung cancer associated fibroblasts isolated from patients. We also employ molecular dynamics simulations to study the atomic-scale mechanisms that dictate how [email protected]82(OH)22 mediates interactions between TNFα and TNFRs. Our data suggest that [email protected]82(OH)22 might enhance the association between TNFα and TNFR2 through a “bridge-like” mode of interaction; by contrast, the fullerenol appears to inhibit TNFα-TNFR1 association by binding to two of the receptor's cysteine-rich domains. In concert, our results uncover a sequential, systemic process by which [email protected]82(OH)22 acts to prison tumor cells, providing new insights into principles of designs of cancer therapeutics.
科研通智能强力驱动
Strongly Powered by AbleSci AI